Weekly Digest – 17-23 Jun 2023 Weekly Digest – 17-23 Jun 2023 20 Jun 2023: Talzenna (Talazoparib) / Xtandi (Enzalutamide) / mCRPC / Pfizer: Received US FDA approval This approval was based on the positive data from the Phase 3 […]
Weekly Digest – 17-23 Jun 2023 Weekly Digest – 17-23 Jun 2023 20 Jun 2023: Keytruda / Gastroesophageal Junction Adenocarcinoma / Merck: Phase 3 KEYNOTE-585 Trial met one of its primary endpoints of pCR Merck announced topline results from Phase […]
Weekly Digest – 17-23 Jun 2023 Weekly Digest – 17-23 Jun 2023 20 Jun 2023: Adcetris (Brentuximab vedotin) / Classical Hodgkin Lymphoma (cHL) / Seagen: Phase 3 GHSG’s HD21 trial met its co-primary endpoints Seagen reported positive data from the […]
Weekly Digest – 17-23 Jun 2023 Weekly Digest – 17-23 Jun 2023 17 Jun 2023: Breyanzi / Follicular Lymphoma / Mantle Cell Lymphoma / BMS: TRANSCEND clinical trials delivered deep and durable responses BMS announced the initial disclosure of the […]
